Non-Invasive Prenatal Testing (NIPT)

Non-Invasive Prenatal Testing (NIPT) can detect genetic disorders using a small blood sample taken during pregnancy. By analysing the presence of cell-free foetal DNA in the blood, it can confirm whether a baby is at higher risk of being born with a genetic disease such as Down, Edwards or Patau syndromes.
What is Non-Invasive Prenatal Testing (NIPT)?

What is Non-Invasive Prenatal Testing (NIPT)?


When is it recommended?

NIPT is often recommended for women with a high risk of chromosomal abnormalities following their 1st trimester screening (hormone analysis and ultrasound scan). Your consultant may also recommend it if you are 35 years or older or if genetic disorders have affected your family or previous pregnancies. This test is also recommended in cases of multiple pregnancies.


For over 30 years, IVI has helped more than 200,000 dreams come true.


97% of our patients recommend IVI. We’re with you at every stage of your treatment, providing support and care.


IVI has a worldwide reputation for innovative research and has developed and patented pioneering techniques and technologies.


IVI is one of the largest fertility treatment providers in the world, with more than 65 clinics in 9 countries.





Request your first appointment

Back to toparrow_drop_up